氨基酰-tRNA合成酶催化tRNA的氨基酰化反应为生物体内的蛋白质合成提供原料.这类古老且保守的蛋白质分子在高等生物复杂的细胞分子网络中分化出的新功能是目前人们关注的焦点.近期在对一些患有神经退行性疾病的病人和小鼠模型的研究中发现,位于酪氨酰-tRNA合成酶、甘氨酰-tRNA合成酶和丙氨酰-tRNA合成酶上的突变,可分别导致DI腓骨肌萎缩症(Charcot-Marie-Toothdisease,CMT)C型,腓骨肌萎缩症2D型及小脑浦肯雅(Purkinje)细胞丢失.初步的致病机理研究表明,致病突变对这3种酶的影响各不相同:酪氨酰-tRNA合成酶的氨基酰化催化能力受到影响,甘氨酰-tRNA合成酶受影响的可能是一种未知的新功能,而丙氨酰-tRNA合成酶受影响的则是它的编校功能.这些研究结果揭示了氨基酰-tRNA合成酶涉及神经退行性疾病的广泛性和其机制的复杂性,并将促进对神经退行性疾病这一类常见疾病的病理和治疗方法的研究.
Aminoacyl-tRNA synthetases (AARSs) catalyze aminoacylation of their tRNAs for protein biosynthesis. As belong to one of the most ancient and conserved enzyme family their additional functions in mammalian cells were focused recently. Mutations in tyrosyl-tRNA synthetase, glycyl-tRNA synthetase and alanyl-tRNA synthetase from patients and mice models were identified to cause two subtypes of Charcot-Marie-Tooth disease and cerebellar Purkinje cell loss, respectively. These mutations affect different functions of the three enzymes including aminoacylation, editing and unknown functions. These results combined AARSs with neurodegeneration and gave new sights into neuropathy.